期刊文献+

对高危前列腺癌患者进行腹腔镜下前列腺癌根治术和内分泌辅助治疗的效果观察 被引量:4

To observe the effect of laparoscopic radical resection and endocrine adjuvant therapy for high-risk prostate cancer patients
下载PDF
导出
摘要 目的 :探讨对高危前列腺癌患者进行腹腔镜下前列腺癌根治术和内分泌辅助治疗的临床效果。方法 :将近年内简阳市人民医院收治的106例高危前列腺癌患者作为研究对象。将这106例患者随机平均分为对照组和观察组。对对照组患者进行开放式根治性前列腺切除术。对观察组患者进行腹腔镜下前列腺癌根治术和内分泌辅助治疗。然后,比较两组患者手术的各项指标,其治疗的总有效率及其1年后病情的复发率。结果 :与对照组患者相比,观察组患者术中出血量更少,其手术的时间及肠功能恢复的时间均更短,其治疗的总有效率更高,其1年后病情的复发率更低,P <0.05。结论 :对高危前列腺癌患者进行腹腔镜下前列腺癌根治术和内分泌辅助治疗的效果显著,且安全性高。 objective: to explore the clinical effect of laparoscopic radical resection of prostate cancer and endocrine adjuvant therapy for high-risk prostate cancer patients. Methods: 106 high-risk prostate cancer patients admitted by people's hospital of jianyang city were studied in recent years. The 106 patients were randomly divided into a control group and an observation group. Open radical prostatectomy was performed on the control group. The patients in the observation group were treated with laparoscopic radical resection of prostate cancer and endocrine adjuvant therapy. Then, the total effective rate of treatment and the recurrence rate after 1 year were compared between the two groups. Results: compared with the control group, the patients in the observation group had less intraoperative blood loss, shorter operative time and bowel function recovery time, higher overall therapeutic efficiency, and lower recurrence rate after 1 year, P 0.05. Conclusion: laparoscopic radical prostatectomy and endocrine adjuvant therapy for high-risk prostate cancer patients are effective and safe.
作者 彭波 Peng Bo(People's hospital of jianyang city,Jianyang Sichuan 641400)
机构地区 简阳市人民医院
出处 《当代医药论丛》 2018年第17期98-99,共2页
关键词 高危前列腺癌 腹腔镜下前列腺癌根治术 内分泌辅助治疗 high-risk prostate cancer Laparoscopic radical resection of prostate cancer Endocrine adjuvant therapy
  • 相关文献

参考文献4

二级参考文献64

  • 1BAADE PD, YOULDEN DR, KRNJACKI KI. International epi- demiology of prostate cancer:geographical distribution and secular trends[J]. Mol Nutr Food Res, 2009, 53(2): 171-184.
  • 2EIFLER JB, FENG Z, LIN BM, et al. An updated prostate can- cer staging nomogram (Partin tables) based on cases from 2006 to 2011[J]. BJU Int, 2013, 111(1): 22-29.
  • 3LEE WR. Improvement in prostate cancer survival over time: a 20- year analysis: the Will Rogers phenomenon returns [J]. Can- cer J, 2012, 18(1): 9-10.
  • 4MOHLER J, BAHNSON RR, BOSTON B, et al. NCCN clinical practice guidelines in oncology: prostate cancer [J]. J Natl Compr Cane Netw, 2010, 8(2): 162-200.
  • 5MOTTET N, BELLMUNT J, BOLLA M, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castrationresistant prostate cancer [J]. Eur Urol, 2011, 59(4): 572-583.
  • 6EGGENER SE, SCARDINO PF, WALSH PC, et al. Predicting 15-year prostate cancer specific mortality after radical prostatec- tomy[J]. J Urol, 2011, 185(3): 869-875.
  • 7MARIA CM, JIANBO L, JOSEPH CK, et al. Optimal definition of biochemical recurrence after radical prostatectomy depends on pathologic risk factors: identifying candidates for early salvage therapy [J/OL]L (2013. 08. 20) [2013. 08. 30]. httlx // d dot. org/ 10.1016/ j. eururo. 2013. 08. 022.
  • 8TAKU NAIKI, NORIYASU KAWAI, TAKEHIKO OKAMURA, et al. Neoadjuvant hormonal therapy is a feasible option in laparo- seopic radical prostatectomy[J]. BMC Urology, 2012, 18(12): 36.
  • 9BRIGANTI A, SPAHN M, JONIAU S, et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a muhi-insti- tutional competing-risks analysis [J]. Eur Urol, 2013, 63 (4): 693-701.
  • 10SHELLEY DM, KUMAR S , WILT T, et al. A systematic re- view and meta-analysis of randomized trials of neo-adjuvant hormone therapy for localized and locally advanced prostate car- cinoma[J]. Cancer Treatment Reviews, 2009, 35(1): 9-17.

共引文献71

同被引文献37

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部